HCID 59578523, 화합물 → HCID 66955547, 화합물
반응식
Cl[C:2]1[C:7]([CH:8]([CH2:13][CH2:14][CH3:15])[C:9]([O:11][CH3:12])=[O:10])=[C:6]([CH3:16])[N:5]=[C:4]([N:17]2[CH2:22][CH2:21][CH2:20][CH2:19][CH2:18]2)[N:3]=1.[O:23]1[C:34]2[C:35]3[C:30]([C:31](B(O)O)=[CH:32][CH:33]=2)=[N:29][CH:28]=[CH:27][C:26]=3[CH2:25][CH2:24]1>>[O:23]1[C:34]2[C:35]3[C:30]([C:31]([C:2]4[C:7]([CH:8]([CH2:13][CH2:14][CH3:15])[C:9]([O:11][CH3:12])=[O:10])=[C:6]([CH3:16])[N:5]=[C:4]([N:17]5[CH2:22][CH2:21][CH2:20][CH2:19][CH2:18]5)[N:3]=4)=[CH:32][CH:33]=2)=[N:29][CH:28]=[CH:27][C:26]=3[CH2:25][CH2:24]1참가 물질
3
실험 절차
This compound is prepared according to general method E starting from methyl 2-(4-chloro-6-methyl-2-(piperidin-1-yl)pyrimidin-5-yl)pentanoate and 2,3-dihydropyrano[4,3,2-de]quinolin-7-ylboronic acid.
후처리
- customThis compound is prepared
출처 및 근거
- ORD 기록
- ord-62af4664b8f54e89baf8233ce677e90f
- 출처 데이터셋
- uspto-grants-2014_12